Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora
Open Access
- 1 January 1986
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 29 (1) , 44-48
- https://doi.org/10.1128/aac.29.1.44
Abstract
The mechanism of toxicity from 5-fluorocytosine chemotherapy is unclear. However, recent evidence suggests that the generation of 5-fluorouracil by a host may play an important role in the development of this toxicity. Using an in vitro semicontinuous culture system to mimic the intestinal microflora, we examined the capacity of this complex microbial community to convert 5-fluorocytosine to 5-fluorouracil. The system was dosed initially and after 2 weeks of chronic exposure to 5-fluorocytosine with radiolabeled 5-fluorocytosine. No detectable production of 5-fluorouracil was observed up to 8 h after the acute dose; however, at 24 h and at all time points thereafter, increasing levels of 5-fluorouracil were detected for 4 days. The chronic dose resulted in an increased rate of 5-fluorouracil production without the 8-h lag time. These findings suggest that the enzyme or enzymes responsible for the deamination of 5-fluorocytosine to 5-fluorouracil by the intestinal microflora can be induced by chronic exposure to 5-fluorocytosine and that this conversion may provide a mechanism through which 5-fluorocytosine toxicity is manifested.This publication has 21 references indexed in Scilit:
- Identification of minor metabolites of 5-fluorocytosine in man by chemical ionization gas chromatography mass spectrometryJournal of Mass Spectrometry, 1981
- A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal MeningitisNew England Journal of Medicine, 1979
- Evidence for Conversion of 5-Fluorocytosine to 5-Fluorouracil in Humans: Possible Factor in 5-Fluorocytosine Clinical ToxicityAntimicrobial Agents and Chemotherapy, 1978
- Biochemical Pharmacology of the Intestinal FloraAnnual Review of Pharmacology and Toxicology, 1978
- Pretreatment methods prior to gaschromatographic analysis of volatile fatty acids from faecal samplesClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Metabolic Studies with 5-Fluorocytosine-6-14C in Mouse, Rat, Rabbit, Dog and ManChemotherapy, 1976
- Therapy of Cryptococcosis with a Combination of Flucytosine and Amphotericin BThe Journal of Infectious Diseases, 1975
- Mode of Action of 5-Fluorocytosine and Mechanisms of ResistanceChemotherapy, 1975
- Flucytosine. An effective oral treatment for chromomycosisArchives of Dermatology, 1974
- Determination of organic acids of low relative molecular mass (C1 to C4) in dilute aqueous solutionThe Analyst, 1974